Table 9.
Metabolites and their pathways which correlate with aberrant behavior.
| Significant Metabolites | Significant Pathways | |||
|---|---|---|---|---|
| Metabolite | r | Pathway | Matched Metabolites | Impact |
| L-3-Phenyllactic acid *** | −0.39 | Phenylalanine metabolism ** |
Phenylpyruvate **,
2-Hydroxyphenylacetate * |
0.26 |
| Phenylpyruvic acid ** | −0.35 | |||
| D-Leucic acid ** | −0.34 | Phenylalanine, tyrosine and tryptophan biosynthesis * | Phenylpyruvate ** | 0 |
| Guanine * | −0.26 | |||
| 3-Hexenedioic acid * | −0.25 | |||
| L-Arabinose * | 0.25 | |||
| Ortho-Hydroxyphenylacetic acid * | −0.25 | |||
| Amiloride * | 0.24 | |||
| Glucuronic acid * | −0.24 | |||
| 3S-methyl-2-oxo-pentanoic acid * | −0.23 | |||
| Cytidine * | 0.23 | |||
| L-Alpha-aminobutyric acid * | −0.23 | |||
| 3-Hydroxyisovaleric acid * | −0.22 | |||
| Caprylic acid * | −0.22 | |||
* p ≤ 0.05, ** p ≤ 0.01; *** p ≤ 0.001.